Methods for Missing Data Handling in Randomized Clinical Trials With Nonnormal Endpoints With Application to a Phase III Clinical Trial

被引:4
|
作者
Fan, Chunpeng [1 ]
Zhang, Donghui [1 ]
Wei, Lynn [1 ]
Koch, Gary [1 ]
机构
[1] Sanofi US Inc, Dept Biostat & Programming, 55 Corp Dr, Bridgewater, NJ 08807 USA
来源
关键词
MAR; Missing at random; Missing not at random; MNAR; Nonparametric; Rank; MULTIVARIATE INCOMPLETE DATA; PATTERN-MIXTURE MODELS; NONPARAMETRIC METHODS; DROP-OUT; RHEUMATOID-ARTHRITIS; MIXED MODELS; COVARIANCE; MECHANISM;
D O I
10.1080/19466315.2016.1142890
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In randomized clinical trials, when the endpoint is the change from baseline at the last scheduled visit, various parametric, semiparametric, and nonparametric methods have been developed to handle the possible missing data due to dropouts. Although the last observation carried forward (LOCF) and the mixed-effects model for repeated measures (MMRM) have been extensively compared and widely used, they may lead to biased results when the required distributional or missing mechanism assumptions are not satisfied. Nonparametric missing data handling methods including the last rank carried forward (LRCF) and mean rank imputation (MRI) relax the underlying distributional assumptions; however, conditions for them to be valid have been investigated to a very limited extent. This article rigorously derives asymptotic properties of the MRI method and proves its validity to test the primary endpoint under certain mild distributional and missing mechanism assumptions. The test-based estimator for the location difference between the treatment and the control groups is also derived when the randomized clinical trial has two arms under a location shift assumption. The investigated methods are applied to an illustrative phase III clinical trial. Simulation studies based on the empirical distributions from the illustrative clinical trial and additional intensive simulation studies, based on various prespecified distributions and missing mechanisms, were conducted to compare the MRI method with selected traditional methods including LOCF, MMRM, and LRCF and they confirmed the better performance of the MRI method in terms of the Type I error rate control and the power under certain mild conditions.
引用
收藏
页码:179 / 193
页数:15
相关论文
共 50 条
  • [1] Methods for Missing Data Handling in Phase III Clinical Trials with Nonnormal Endpoints and Nonnormal Covariates
    Fan, Chunpeng
    Wei, Lynn
    Koch, Gary G.
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2020, 12 (01): : 68 - 78
  • [2] Commentary: Indefensible Methods of Handling Missing Data in Clinical Trials
    Arndt, Stephan
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (12) : 1997 - 1998
  • [3] MISSING DATA HANDLING METHODS IN MEDICAL DEVICE CLINICAL TRIALS
    Yan, Xu
    Lee, Shiowjen
    Li, Ning
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 1085 - 1098
  • [4] MISSING RADIOGRAPHIC DATA HANDLING IN RANDOMIZED CLINICAL TRIALS IN RHEUMATOID ARTHRITIS
    Huang, Xiaohong
    Jiao, Lixia
    Wei, Lynn
    Quan, Hui
    Teoh, Leah
    Koch, Gary G.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (06) : 1435 - 1452
  • [5] Methods for handling missing values in clinical trials
    Little, RJA
    [J]. JOURNAL OF RHEUMATOLOGY, 1999, 26 (08) : 1654 - 1656
  • [6] Handling missing data in clinical trials: An overview
    Myers, WR
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (02): : 525 - 533
  • [7] Handling Missing Data in Clinical Trials: An Overview
    William R. Myers
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (2): : 525 - 533
  • [8] The methods for handling missing data in clinical trials influence sample size requirements
    Auleley, GR
    Giraudeau, B
    Baron, G
    Maillefert, JF
    Dougados, M
    Ravaud, P
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (05) : 447 - 453
  • [9] Currently available guidance on missing data handling in randomized clinical trials: a scoping exercise
    Krepper, Daniela
    Martini, Caroline
    Sztankay, Monika
    [J]. QUALITY OF LIFE RESEARCH, 2022, 31 : S127 - S127
  • [10] Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
    Victoria J. Serpas
    Kanwal P. Raghav
    Daniel M. Halperin
    James Yao
    Michael J. Overman
    [J]. BMC Medical Research Methodology, 18